Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,740 public trials 634 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

NCT04178967

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Investigate MD Scottsdale, Arizona, United States
  • Northwest Arkansas Clinical Trials Center Rogers, Arkansas, United States
  • Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States
  • Center For Dermatology Clinical Research, Inc. Fremont, California, United States
View all 89 locations
View Trial Details
Completed

Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

NCT04976868

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Beijing children's Hospital, Capital Medical University Beijing, China
  • Beijing Hospital Beijing, China
  • Children's Hospital Capital Institute of Pediatrics Beijing, China
  • Peking University First Hospital Beijing, China
View Trial Details
Completed

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

NCT00130351

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Allergy and Asthma Specialists Medical Group and Research Ct Huntington Beach, California, United States
  • Allergy and Asthma Medical Group & Research Center San Diego, California, United States
  • Allergy & Asthma Associates of Santa Clara Res. Center San Jose, California, United States
  • Colorado Allergy and Asthma Centers, PC Denver, Colorado, United States
View Trial Details
Completed

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

NCT04305405

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +7 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Orlando, Florida, United States
  • Research Site Lincoln, Nebraska, United States
  • Research Site Cincinnati, Ohio, United States
View all 15 locations
View Trial Details

Related conditions